Showing results (91-100 of 2,158) with videos related to
Sort By:
Pageof 216
Journal of Biopharmaceutical Statistics|March 1, 1995
The impact of outlying subjects on decision of bioequivalenceF Y Ki, J P Liu, W Wang, et al.Journal of Biopharmaceutical Statistics|March 1, 1993
Statistical methods for a three-period crossover design in which high dose cannot be used firstK E Peace, G G KochJournal of Biopharmaceutical Statistics|March 1, 1993
Analysis of the 2 x 2 crossover design with subsamplingJ M Grender, W D JohnsonJournal of Biopharmaceutical Statistics|March 1, 1993
A simple stopping rule for declaring treatment ineffectiveness in clinical trialsG G Enas, W W OffenJournal of Biopharmaceutical Statistics|March 1, 1993
The likelihood ratio for comparing means when a portion of the subjects fail to respondW D Johnson, A M KellyJournal of Biopharmaceutical Statistics|July 1, 1996
Errors in time in pharmacokinetic studiesX Jia, J R NedelmanJournal of Biopharmaceutical Statistics|November 1, 1996
The cardinal features of cognitive and noncognitive dysfunction and the differential efficacy of tacrine in Alzheimer's disease patientsS TalwalkerJournal of Biopharmaceutical Statistics|November 1, 1996
Etrank: a ranking procedure for handling missing data in clinical trials: application to venlafaxine extended-release depression clinical trialR EntsuahJournal of Biopharmaceutical Statistics|November 1, 1996
Uniform matrix stability study designsJ R MurphyJournal of Biopharmaceutical Statistics|December 31, 2010
A new outlier identification test for method comparison studies based on robust regressionGeraldine Rauch, Andrea Geistanger, Jürgen TimmPageof 216